Literature DB >> 27031988

Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Eleanor A Powell1, Ceejay L Boyce1, Maemu P Gededzha2, Selokela G Selabe2, M Jeffrey Mphahlele3, Jason T Blackard4.   

Abstract

Occult hepatitis B is defined by the presence of hepatitis B virus (HBV) DNA in the absence of hepatitis B surface antigen (HBsAg). Occult HBV is associated with the development of hepatocellular carcinoma, reactivation during immune suppression, and virus transmission. Viral mutations contribute significantly to the occult HBV phenotype. Mutations in the 'a' determinant of HBsAg are of particular interest, as these mutations are associated with immune escape, vaccine escape and diagnostic failure. We examined the effects of selected occult HBV-associated mutations identified in a population of HIV-positive South Africans on HBsAg production in vitro. Mutations were inserted into two different chronic HBV backbones and transfected into a hepatocyte-derived cell line. HBsAg levels were quantified by enzyme-linked immunosorbent assay (ELISA), while the detectability of mutant HBsAg was determined using an HA-tagged HBsAg expression system. Of the seven mutations analysed, four (S132P, C138Y, N146D and C147Y) resulted in decreased HBsAg expression in one viral background but not in the second viral background. One mutation (N146D) led to a decrease in HBsAg detected as compared to HA-tag, indicating that this mutation compromises the ability of the ELISA to detect HBsAg. The contribution of occult-associated mutations to the HBsAg-negative phenotype of occult HBV cannot be determined adequately by testing the effect of the mutation in a single viral background, and rigorous analysis of these mutations is required.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27031988      PMCID: PMC5756483          DOI: 10.1099/jgv.0.000469

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  60 in total

1.  De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the "a" determinant.

Authors:  E M Yoshida; A Ramji; S R Erb; J E Davis; U P Steinbrecher; C H Sherlock; C H Scudamore; S W Chung; M Williams; K S Gutfreund
Journal:  Liver       Date:  2000-10

2.  Genome-wide networks of amino acid covariances are common among viruses.

Authors:  Maureen J Donlin; Brandon Szeto; David W Gohara; Rajeev Aurora; John E Tavis
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: A 3-year study of national surveillance of primary school students.

Authors:  Ching-Yi Chen; Hong-Yuan Hsu; Cheng-Chuan Liu; Mei-Hwei Chang; Yen-Hsuan Ni
Journal:  Vaccine       Date:  2010-06-21       Impact factor: 3.641

4.  Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient.

Authors:  S Seddigh-Tonekaboni; W L Lim; B Young; J L Hou; J Waters; K X Luo; H C Thomas; P Karayiannis
Journal:  J Viral Hepat       Date:  2001-03       Impact factor: 3.728

5.  Assessment of CXCL12 (SDF-1α) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran.

Authors:  Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi; Hossein Khoramdelazad; Narges Yaghini; Ebrahim Rezazadeh Zarandi
Journal:  Arch Med Res       Date:  2010-07       Impact factor: 2.235

6.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; Cheuk-Kwong Lee; Yasuhito Tanaka; Jean-Pierre Allain; James Fung; Jennifer Leung; Che-Kit Lin; Masaya Sugiyama; Fuminaka Sugauchi; Masashi Mizokami; Ching-Lung Lai
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

8.  Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.

Authors:  Xiu-Ji Cui; Yoo-Kyung Cho; Byung-Cheol Song
Journal:  J Med Virol       Date:  2015-01-21       Impact factor: 2.327

9.  Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.

Authors:  Azwidowi Lukhwareni; Rosemary J Burnett; S Gloria Selabe; M Olga Mzileni; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2009-03       Impact factor: 2.327

10.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more
  4 in total

1.  Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.

Authors:  Mikael Gencay; Kirsten Hübner; Peter Gohl; Anja Seffner; Michael Weizenegger; Dionysios Neofytos; Richard Batrla; Andreas Woeste; Hyon-Suk Kim; Gaston Westergaard; Christine Reinsch; Eva Brill; Pham Thi Thu Thuy; Bui Huu Hoang; Mark Sonderup; C Wendy Spearman; Stephan Pabinger; Jérémie Gautier; Giuseppina Brancaccio; Massimo Fasano; Teresa Santantonio; Giovanni B Gaeta; Markus Nauck; Wolfgang E Kaminski
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

2.  In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Authors:  Motswedi Anderson; Wonderful T Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo B Phinius; Lynette Bhebhe; Theresa K Sebunya; Joseph Makhema; Richard Marlink; Anna Kramvis; Max Essex; Rosemary M Musonda; Jason T Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

Review 3.  Hepatitis B Virus Research in South Africa.

Authors:  Mohube B Maepa; Abdullah Ely; Anna Kramvis; Kristie Bloom; Kubendran Naidoo; Omphile E Simani; Tongai G Maponga; Patrick Arbuthnot
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

4.  Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Authors:  Motswedi Anderson; Wonderful Tatenda Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo Bonita Phinius; Lynnette Bhebhe; Theresa Kibirige Sebunya; Shahin Lockman; Richard Marlink; Anna Kramvis; Max Essex; Rosemary Mubanga Musonda; Jason Tory Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-09-07       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.